ALISSA LUMETTA: Open Payments
NPI 1457920126 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,795 in 100 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,795
Food & beverage: $2,640Education: $155
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $639 |
| UCB, Inc. | 22 | $532 |
| Novartis Pharmaceuticals Corporation | 15 | $340 |
| ABBVIE INC. | 7 | $308 |
| Amgen Inc. | 14 | $203 |
| ANI Pharmaceuticals, Inc. | 7 | $158 |
| Organon LLC | 7 | $129 |
| United Therapeutics Corporation | 2 | $121 |
| Sandoz Inc. | 4 | $98 |
| Genentech USA, Inc. | 4 | $78 |
Products named: TREMFYA, Bimzelx, COSENTYX, RINVOQ, PURIFIED CORTROPHIN GEL, OTEZLA, HADLIMA, KRYSTEXXA.
Industry payments across MI — which companies pay providers there.
